Corcept Therapeutics (CORT) Other Working Capital Changes (2010 - 2026)
Corcept Therapeutics recorded quarterly Other Working Capital Changes of -$4.7 million in Q1 2026, down 63.54% quarter-over-quarter from -$2.9 million in Q4 2025, and down 135.02% year-over-year from $13.5 million in Q1 2025.
Corcept Therapeutics' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$4.7 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 135.02% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$19.7 million (down 214.6% YoY), while the FY2025 annual figure was -$1.5 million, down 2211.59% from the prior year.
- Other Working Capital Changes came in at -$4.7 million for Q1 2026 at Corcept Therapeutics, down from -$2.9 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $13.5 million in Q1 2025 to a low of -$11.3 million in Q2 2025.
- A 5-year average of -$177733.3 and a median of -$793000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes plunged 1538.24% in 2022 and surged 474.45% in 2025, its largest moves.
- Corcept Therapeutics' Other Working Capital Changes stood at $3.6 million in 2022, then declined by 25.26% to $2.7 million in 2023, then jumped by 216.2% to $8.5 million in 2024, then tumbled by 133.95% to -$2.9 million in 2025, then plunged by 63.54% to -$4.7 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$4.7 million, -$2.9 million, and -$793000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.74 Mn |
| Mar 31, 2026 | -4.74 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Sep 30, 2025 | -793,000.00 |
| Sep 30, 2025 | -793,000.00 |
| Jun 30, 2025 | -11.29 Mn |
| Jun 30, 2025 | -11.29 Mn |
| Mar 31, 2025 | 13.53 Mn |
| Mar 31, 2025 | 13.53 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | -8.86 Mn |
| Sep 30, 2024 | -8.86 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | -3.61 Mn |
| Mar 31, 2024 | -3.61 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Dec 31, 2022 | 3.61 Mn |
| Dec 31, 2022 | 3.61 Mn |
| Sep 30, 2022 | -557,000.00 |
| Sep 30, 2022 | -557,000.00 |
| Jun 30, 2022 | -1.09 Mn |
| Jun 30, 2022 | -1.09 Mn |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | -1.02 Mn |
| Dec 31, 2021 | -1.02 Mn |
| Sep 30, 2021 | -34,000.00 |
| Sep 30, 2021 | -34,000.00 |
| Jun 30, 2021 | -376,000.00 |
| Jun 30, 2021 | -376,000.00 |
| Mar 31, 2021 | -484,000.00 |
| Mar 31, 2021 | -484,000.00 |
| Dec 31, 2020 | 2.76 Mn |
| Dec 31, 2020 | 2.76 Mn |
| Sep 30, 2020 | -484,000.00 |
| Sep 30, 2020 | -484,000.00 |
| Jun 30, 2020 | -372,000.00 |
| Jun 30, 2020 | -372,000.00 |
| Mar 31, 2020 | -349,000.00 |
| Mar 31, 2020 | -349,000.00 |
| Dec 31, 2019 | 4.51 Mn |
| Dec 31, 2019 | 4.51 Mn |
| Sep 30, 2019 | -378,000.00 |
| Sep 30, 2019 | -378,000.00 |
| Jun 30, 2019 | 1.27 Mn |
| Jun 30, 2019 | 1.27 Mn |
| Mar 31, 2019 | -2.00 Mn |
| Mar 31, 2019 | -2.00 Mn |
| Dec 31, 2018 | 5.07 Mn |
| Dec 31, 2018 | 5.07 Mn |
| Sep 30, 2018 | -907,000.00 |
| Sep 30, 2018 | -907,000.00 |
| Jun 30, 2018 | 887,000.00 |
| Jun 30, 2018 | 887,000.00 |
| Mar 31, 2018 | 23,000.00 |
| Mar 31, 2018 | 23,000.00 |
| Dec 31, 2017 | -417,000.00 |
| Dec 31, 2017 | -417,000.00 |
| Sep 30, 2017 | 559,000.00 |
| Sep 30, 2017 | 559,000.00 |
| Jun 30, 2017 | 538,000.00 |
| Jun 30, 2017 | 538,000.00 |
| Mar 31, 2017 | 25,000.00 |
| Mar 31, 2017 | 25,000.00 |
| Dec 31, 2016 | 158,000.00 |
| Dec 31, 2016 | 158,000.00 |
| Sep 30, 2016 | -158,000.00 |
| Sep 30, 2016 | -158,000.00 |
| Jun 30, 2016 | 158,000.00 |
| Jun 30, 2016 | 158,000.00 |
| Mar 31, 2016 | -158,000.00 |
| Mar 31, 2016 | -158,000.00 |
| Dec 31, 2015 | -538,000.00 |
| Dec 31, 2015 | -538,000.00 |
| Sep 30, 2015 | -269,000.00 |
| Sep 30, 2015 | -269,000.00 |
| Jun 30, 2015 | 827,000.00 |
| Jun 30, 2015 | 827,000.00 |
| Mar 31, 2015 | -819,000.00 |
| Mar 31, 2015 | -819,000.00 |
| Dec 31, 2014 | 540,000.00 |
| Dec 31, 2014 | 540,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | -94,000.00 |
| Dec 31, 2013 | -94,000.00 |
| Sep 30, 2013 | 203,000.00 |
| Sep 30, 2013 | 203,000.00 |
| Jun 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 121,000.00 |
| Mar 31, 2013 | 60,000.00 |
| Mar 31, 2013 | 60,000.00 |
| Dec 31, 2012 | -8,000.00 |
| Dec 31, 2012 | -8,000.00 |
| Sep 30, 2012 | -29,000.00 |
| Sep 30, 2012 | -29,000.00 |
| Jun 30, 2012 | 64,000.00 |
| Jun 30, 2012 | 64,000.00 |
| Mar 31, 2012 | -38,000.00 |
| Mar 31, 2012 | -38,000.00 |
| Dec 31, 2011 | -81,000.00 |
| Dec 31, 2011 | -81,000.00 |
| Sep 30, 2011 | -28,000.00 |
| Sep 30, 2011 | -28,000.00 |
| Jun 30, 2011 | -149,000.00 |
| Jun 30, 2011 | -149,000.00 |
| Mar 31, 2011 | 186,000.00 |
| Mar 31, 2011 | 186,000.00 |
| Dec 31, 2010 | -37,000.00 |
| Dec 31, 2010 | -37,000.00 |
| Sep 30, 2010 | 55,000.00 |
| Sep 30, 2010 | 55,000.00 |